- US100 edges higher after the U.S. market open
- Uranium stocks under pressure following Trump–Putin call
- Progyny shares drop over 10%
- Niles Investment Management sees no repeat of 2008 scenario
- Moody’s says there are no signs of US systemic credit contagion
- US100 edges higher after the U.S. market open
- Uranium stocks under pressure following Trump–Putin call
- Progyny shares drop over 10%
- Niles Investment Management sees no repeat of 2008 scenario
- Moody’s says there are no signs of US systemic credit contagion
U.S. indices are posting slight gains on Friday, with regional banks slowly rebounding after recent losses. The US100 index is up 0.1%, holding above the 50-day EMA (orange line).
Source: xStation5
Trump’s IVF initiative may have a “nuanced” impact on Progyny shares, stock down 13%. On Thursday, the Trump administration announced an initiative aimed at expanding access to in vitro fertilization (IVF) procedures. Until now, their use has been limited by high costs and the fact that they are not always covered by health insurance.
- In response to the news, Progyny — a company specializing in fertility-related healthcare benefits — saw its shares fall 13% on Friday morning, as investors assessed the potential consequences of the announcement.
- According to Bank of America, the president’s actions are potentially positive for Progyny, but “the actual impact may be more nuanced.” Lutz pointed out that the government’s proposal still lacks details, and it remains unclear whether potential cost reductions would translate into higher procedure volumes and greater demand for insurance coverage.
As a market leader with broad geographic reach, Progyny appears well positioned to benefit from any increase in accessibility and demand for IVF procedures, Lutz added, maintaining a buy rating on the stock.
Source: xStation5
Uranium Energy Corp. (UEC.US) is down more than 10%, with the broader uranium sector also under pressure — from Kazakh miner Kazatomprom (KAP.UK) to Canada’s Cameco (CCJ.US) — suggesting that the driver of the declines extends beyond the U.S. market. In addition to profit-taking following record price gains, the sell-off may also be linked to the renewed contact between Trump and Putin, which could imply the absence of strict sanctions on Russian uranium and processing. That, in turn, could lead to a decline in spot prices.
Source: xStation5
VIX drops 10% amid Wall Street rebound attemptđź—˝
3 markets to watch next week - (17.10.2025)
Fed's Musalem remarks on the US economy and tariffsđź—˝
Precious metals decline 📉Gold down 2%; Silver loses 4%
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
